The Efficacy, Safety, and Persistence of Therapy after Non-Medical Switching from an Originator Adalimumab in Inflammatory Bowel Disease: Real-Life Experience from Two Tertiary Centres

• Main Authors: Teodora Spataru (Author), Remus Popescu (Author), Monica State (Author), Mihai Pahomeanu (Author), Bogdan Mateescu (Author), Lucian Negreanu (Author)
• פורמט: ספר
• יצא לאור: MDPI AG, 2024-10-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

During the last two decades, an increased number of molecules with multiple mechanisms of action have been approved for the treatment of inflammatory bowel disease (IBD), with a substantial increase in the costs related to therapy, which has become a concern for payers, regulators, and healthcare pr...